skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

Medicine (Baltimore), 2017-03, Vol.96 (9), p.e5904-e5904 [Peer Reviewed Journal]

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000005904 ;PMID: 28248853

Full text available

Citations Cited by
  • Title:
    Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
  • Author: Golabi, Pegah ; Fazel, Sofie ; Otgonsuren, Munkhzul ; Sayiner, Mehmet ; Locklear, Cameron T ; Younossi, Zobair M
  • Subjects: Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - surgery ; Cross-Sectional Studies ; Female ; Humans ; Liver Neoplasms - mortality ; Liver Neoplasms - surgery ; Liver Transplantation ; Male ; Middle Aged ; Observational Study ; Retrospective Studies ; SEER Program ; United States - epidemiology
  • Is Part Of: Medicine (Baltimore), 2017-03, Vol.96 (9), p.e5904-e5904
  • Description: Hepatocellular carcinoma (HCC) is among the most common types of cancer. Liver transplantation (LT) and surgical resection (SR) are primary surgical treatment options for HCC.The aim of the study was to assess mortality within 2 years postdiagnosis among patients with HCC according to their treatment modalities.We examined data from the Surveillance, Epidemiology and End Results (SEER)-Medicare database between 2001 and 2009. SEER registries collect demographics, cancer stage and historical types, and treatments. Medicare claims include diagnoses, procedures, and survival status for each beneficiary. Patients with HCC were identified using the International Classification of Disease Oncology, Third Edition Site code C22.0 and Histology Code 8170-8175. Treatment modalities were LT, SR, or nonsurgical treatment.Total of 11,187 cases was included (age at diagnosis: 72 years, 69% male, 67% White). HCC patients who underwent LT were younger (61 vs 71 years), sicker (presence of decompensated cirrhosis: 80% vs 23%), and less likely to die within 2 years (29% vs 44%, all P < 0.01), compared to SR patients. In multivariate analysis, older age (HR: 1.01 [95% CI = 1.01-1.01]), stage of HCC other than local (HR: 1.81[95%CI = 1.70-1.91]), and being treated with SR (HR: 1.95 [95%CI = 1.55-2.46]) were independent predictors of mortality within 2 years. Furthermore, the presence of decompensated cirrhosis (HR: 1.84 [95%CI = 1.73-1.96]) and alcoholic liver disease (HR: 1.19[95%CI = 1.11-1.28]) increased within 2 years mortality.Mortality within 2 years postdiagnosis of HCC was significantly higher in patients treated with SR than LT.
  • Publisher: United States: Wolters Kluwer Health
  • Language: English
  • Identifier: ISSN: 0025-7974
    EISSN: 1536-5964
    DOI: 10.1097/MD.0000000000005904
    PMID: 28248853
  • Source: IngentaConnect
    Journals@Ovid Open Access Journal Collection Rolling
    PubMed Central (Open access)
    Wolters Kluwer Open Health
    MEDLINE
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait